Federation des caisses Desjardins du Quebec’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4K Hold
287
– – ﹤0.01% 2722
2026
Q1
$2.59K Hold
287
– – ﹤0.01% 2627
2025
Q4
$5.24K Hold
287
– – ﹤0.01% 2436
2025
Q3
$4.21K Sell
287
-100
-26% -$1.71K ﹤0.01% 2497
2025
Q2
$7.05K Hold
387
– – ﹤0.01% 2165
2025
Q1
$7.68K Hold
387
– – ﹤0.01% 2044
2024
Q4
$6.64K Hold
387
– – ﹤0.01% 2010
2024
Q3
$7.74K Buy
+387
New +$6.02K ﹤0.01% 1967

Other funds holding ADMA

Federation des caisses Desjardins du Quebec's ADMA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its ADMA Biologics (ADMA) position steady in Q2 2026 at 287 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2722.

Federation des caisses Desjardins du Quebec first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.74K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 287 shares of ADMA Biologics worth $2.4K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its ADMA Biologics share count unchanged in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2722 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Federation des caisses Desjardins du Quebec's ADMA Biologics position peaked at $7.74K in Q3 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.